Lolu lwazi lungenzelwe izinjongo zemfundo kuphela. Aluhloselwe ukuba yiseluleko sezokwelapha. Hlala ubonisana nochwepheshe wezempilo ofanelekile.
Incazelo, Umthamo, Imiphumela Engemihle, Izithiyo. Data from EMA, URPL, openFDA and other regulatory sources.
| Omeprazole | Esomeprazole | |
|---|---|---|
| Izithako Ezisebenzayo | OMEPRAZOLE | ESOMEPRAZOLE |
| Ikhodi ye-ATC | A02BC01 | A02BC01 |
| Isimo | TABLET, DELAYED RELEASE | CAPSULE, DELAYED RELEASE |
| Umthamo | 20 mg/1 | 20 mg/1 |
| Indlela Yokuthatha | ORAL | ORAL |
| Umkhiqizi | Meijer, Inc. | Dolgencorp Inc |
Omeprazole (INN: OMEPRAZOLE, ATC A02BC01) and Esomeprazole (INN: ESOMEPRAZOLE, ATC A02BC01) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Lolu lwazi lungenzelwe izinjongo zemfundo kuphela. Aluhloselwe ukuba yiseluleko sezokwelapha. Hlala ubonisana nochwepheshe wezempilo ofanelekile.